We are live on
!
Find out more
RJA
Raymond James & Associates Portfolio holdings
AUM
$164B
1-Year Est. Return
33.91%
This Fund
S&P 500
This Quarter
Est. Return
+2.42%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$29.6B
AUM Growth
+$1.62B
(+5.8%)
Cap. Flow
+$1.32B
Cap. Flow
% of AUM
4.47%
Top 10 Holdings %
Top 10 Hldgs %
15.49%
Holding
3,030
New
705
Increased
1,212
Reduced
975
Closed
103
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$132M |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$99.6M |
| 3 |
iShares MSCI EAFE ETF
EFA
|
+$74.4M |
| 4 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$61M |
| 5 |
AbbVie
ABBV
|
+$57.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$147M |
| 2 |
iShares MSCI Japan ETF
EWJ
|
+$64.8M |
| 3 |
BRCM
BROADCOM CORP CL-A
BRCM
|
+$56.9M |
| 4 |
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
|
+$53.9M |
| 5 |
Xtrackers MSCI EAFE Hedged Equity ETF
DBEF
|
+$38M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 9.02% |
| 2 | Technology | 8.84% |
| 3 | Financials | 8.13% |
| 4 | Consumer Staples | 8.02% |
| 5 | Industrials | 7.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2151
First Trust Multi Cap Growth AlphaDEX Fund
FAD
$591M
| $404K | ﹤0.01% |
+8,149
| New | +$380K |
|
2152
Fresenius Medical Care
FMS
$13B
| $404K | ﹤0.01% |
+9,173
| New | +$388K |
|
2153
Supernus Pharmaceuticals
SUPN
$2.74B
| $404K | ﹤0.01% |
26,511
+11,312
| +74% | +$148K |
|
2154
United States 12 Month Oil Fund,
USL
$45.6M
| $404K | ﹤0.01% |
24,790
+4,429
| +22% | +$68.5K |
|
|
TA
2155
DELISTED
TravelCenters of America LLC
TA
| $404K | ﹤0.01% |
11,936
+5,074
| +74% | +$196K |
|
2156
Crown Crafts
CRWS
$32M
| $403K | ﹤0.01% |
43,608
+3,300
| +8% | +$28.2K |
|
2157
Murphy Oil
MUR
$5.09B
| $403K | ﹤0.01% |
16,003
+1,312
| +9% | +$26.3K |
|
2158
VeriSign
VRSN
$26.5B
| $402K | ﹤0.01% |
+4,540
| New | +$371K |
|
|
CMA
2159
DELISTED
Comerica
CMA
| $401K | ﹤0.01% |
+10,599
| New | +$382K |
|
|
MFM
2160
Aberdeen Municipal Income Fund
MFM
$222M
| $401K | ﹤0.01% |
56,148
-198,858
| -78% | -$1.39M |
|
|
FNSR
2161
DELISTED
Finisar Corp
FNSR
| $400K | ﹤0.01% |
21,932
+3,215
| +17% | +$46.2K |
|
2162
Ametek
AME
$58B
| $398K | ﹤0.01% |
7,963
-6,180
| -44% | -$294K |
|
|
ARG
2163
DELISTED
Airgas Inc
ARG
| $398K | ﹤0.01% |
+2,810
| New | +$394K |
|
|
TGNA
2164
DELISTED
TEGNA Inc
TGNA
| $397K | ﹤0.01% |
26,472
-12,148
| -31% | -$185K |
|
|
BPY
2165
DELISTED
Brookfield Property Partners L.P. Limited Partnership Units
BPY
| $396K | ﹤0.01% |
17,096
+710
| +4% | +$14.9K |
|
|
VGR
2166
DELISTED
Vector Group Ltd.
VGR
| $395K | ﹤0.01% |
29,626
+2,276
| +8% | +$30.3K |
|
|
IDTI
2167
DELISTED
Integrated Device Technology I
IDTI
| $395K | ﹤0.01% |
19,329
-12,040
| -38% | -$253K |
|
2168
Frontline
FRO
$8.56B
| $394K | ﹤0.01% |
46,496
+8,891
| +24% | +$85.9K |
|
|
IGI
2169
Western Asset Investment Grade Defined Opportunity Trust
IGI
$94.9M
| $393K | ﹤0.01% |
18,775
-600
| -3% | -$12.1K |
|
2170
Transocean
RIG
$6.33B
| $393K | ﹤0.01% |
44,856
-3,105
| -6% | -$30.9K |
|
|
ATRI
2171
DELISTED
Atrion Corp
ATRI
| $393K | ﹤0.01% |
+995
| New | +$376K |
|
2172
Imperial Oil
IMO
$62.3B
| $391K | ﹤0.01% |
11,710
-40
| -0.3% | -$1.25K |
|
|
MACK
2173
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
| $391K | ﹤0.01% |
5,931
+1,546
| +35% | +$80.7K |
|
|
NQM
2174
DELISTED
NUVEEN INVESTMENT QLTY MUNI FD
NQM
| $391K | ﹤0.01% |
24,402
+126
| +0.5% | +$1.98K |
|
2175
First Trust Germany AlphaDEX Fund
FGM
$98.1M
| $390K | ﹤0.01% |
10,644
-20,020
| -65% | -$679K |
|
Similar funds
RJFSA
PI
ECU
EAM
AA
SA
WPL
ECU
Raymond James & Associates's Q1 2016 Portfolio in Review
As of Q1 2016, Raymond James & Associates held 3,030 positions worth $29.6B, up 5.8% from $27.9B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Raymond James & Associates deployed $1.32B of net new capital in Q1 2016, opening 705 new positions and adding to 1,212 existing holdings. Its largest new stake was FlexShares Quality Dividend Index Fund: 874,910 shares worth $31.6M.
By sector, the portfolio is most concentrated in Healthcare at 9% of assets, down from 9.6% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $147M trimmed.
- Raymond James & Associates's largest Q1 2016 buy was FlexShares Quality Dividend Index Fund: 874,910 shares worth $31.6M.
- Raymond James & Associates added most to Vanguard S&P 500 ETF in Q1 2016, an estimated $132M increase.
- Raymond James & Associates's biggest Q1 2016 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $147M.
- Raymond James & Associates fully exited BROADCOM CORP CL-A in Q1 2016, selling an estimated $56.9M.
- Raymond James & Associates's ten largest holdings make up 15% of its $29.6B portfolio in Q1 2016.
- Raymond James & Associates opened 705 new positions and closed 103 in Q1 2016.
- Raymond James & Associates's portfolio value rose 5.8% quarter-over-quarter to $29.6B.
Based on Raymond James & Associates's 13F filing for Q1 2016, filed 12 May 2016.